Cadre Holdings, Inc. (CDRE)
Quantitative Summary
DeterministicAt 29.1x earnings — a 35% discount to the sector average of 44.7x — CDRE is in the lower valuation range. Financial health is average: Piotroski 6/9, Altman Z 3.3.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Cadre Holdings reveal a capital allocation challenge where the return on invested capital sits at 8.9%, falling short of the weighted average cost of capital by 2.5%. This negative spread suggests that current operations are not generating sufficient excess returns to cover their financing costs, even as profitability metrics remain robust with net margins expanding to 7.2% and gross margins holding steady at 42.5%. While revenue growth continues at a moderate 7.5% year-over-year, the DuPont decomposition implies that leverage or asset turnover is insufficient to offset margin-driven ROE pressures. Credit quality indicators present a mixed picture; a Piotroski F-Score of 6/9 signals decent financial strength and operational stability, yet an Altman Z-Score of 3.3 places the firm in the gray zone between safety and distress, while a Beneish M-Score of -2.48 effectively rules out manipulation concerns regarding earnings quality.
Valuation metrics indicate that the market is pricing in significantly higher growth expectations than current fundamentals support. Trading at a forward P/E multiple of 29.1x, the stock commands a substantial discount relative to its industrials sector average of 45.7x, yet this valuation remains elevated when measured against intrinsic value models. A discounted cash flow analysis estimates fair value at $35, implying that current market pricing incorporates aggressive assumptions regarding future margin expansion or capital efficiency improvements that have not yet materialized in the historical data provided. The divergence between the sector's premium multiple and Cadre's lower multiple reflects specific risk premiums for its business model rather than a broad industrial valuation compression.
The synthesis of these factors presents a nuanced risk-reward profile where operational integrity is supported by strong earnings quality scores, but capital efficiency lags behind financing costs. Investors must weigh whether the current valuation gap relative to sector peers adequately compensates for the negative ROIC-WACC spread and the borderline credit health indicated by the Altman score. The absence of insider activity data in this dataset prevents further assessment of management alignment with shareholder interests at these price levels, leaving the investment case dependent on future improvements in capital deployment or margin leverage.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 9.3% | 11.3% | 13.3% |
|---|---|---|---|
| 2% | $43 | $32 | $25 |
| 3% | $49 | $35 | $27 |
| 4% | $58 | $40 | $30 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=11.3%, terminal growth 3%. Fair value $35 (+0.0%). Not investment advice.
Valuation Context
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XAR or VIS, the fund manager is mechanically forced to buy or sell CDRE shares regardless of Cadre Holdings, Inc.'s individual fundamentals. We estimate $22M of passive capital is structurally linked to CDRE through 2 tracked ETFs. Passive flows have a limited but growing influence on CDRE's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Cadre Holdings, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Cadre Holdings, Inc. (CDRE) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Caterpillar Inc. (CAT) as the most exposed collateral stock, sharing 1 ETFs with CDRE. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CDRE Ownership Dynamics
ETFs with Highest CDRE Exposure
Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
CDRE Capital Efficiency
How efficiently does Cadre Holdings, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Cadre Holdings, Inc. converts 61% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-2.4%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 17 | $31.28 | $531.76 |
| 2026-05-06 | 22 | $29.85 | $656.7 |
| 2026-05-04 | 3,119 | $29.85 | $93,102.15 |
| 2026-05-01 | 91 | $29.65 | $2,698.15 |
| 2026-04-30 | 291 | $27.38 | $7,967.58 |
| 2026-04-23 | 17 | $29.61 | $503.37 |
| 2026-04-17 | 169 | $30.43 | $5,142.67 |
| 2026-04-09 | 1 | $32.87 | $32.87 |
| 2026-04-07 | 4,721 | $32.56 | $153,715.76 |
| 2026-04-01 | 6,467 | $30.68 | $198,407.56 |
| 2026-03-27 | 2,628 | $30.65 | $80,548.2 |
| 2026-03-19 | 158 | $32.22 | $5,090.76 |
| 2026-03-12 | 84 | $35.21 | $2,957.64 |
| 2026-03-03 | 19 | $46.07 | $875.33 |
| 2026-02-24 | 69 | $42.24 | $2,914.56 |
| 2026-02-20 | 474 | $43.37 | $20,557.38 |
| 2026-02-19 | 131 | $42.64 | $5,585.84 |
| 2026-02-17 | 79 | $42.19 | $3,333.01 |
| 2026-02-09 | 112 | $41.63 | $4,662.56 |
| 2026-02-04 | 90 | $42.00 | $3,780 |
| 2026-01-30 | 4 | $40.14 | $160.56 |
| 2026-01-23 | 240 | $44.17 | $10,600.8 |
| 2025-12-24 | 10 | $42.30 | $423 |
| 2025-12-23 | 4,469 | $42.80 | $191,273.2 |
| 2025-12-22 | 10,852 | $41.61 | $451,551.72 |
| 2025-12-15 | 7,554 | $43.72 | $330,260.88 |
| 2025-12-09 | 1,907 | $42.61 | $81,257.27 |
| 2025-12-08 | 7,369 | $42.85 | $315,761.65 |
| 2025-12-04 | 1,940 | $42.88 | $83,187.2 |
| 2025-12-02 | 13,573 | $42.25 | $573,459.25 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare CDRE to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.